Vektor Medical Secures $16 Million Series A Funding
Digital Health Global
FEBRUARY 5, 2024
Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.
Let's personalize your content